©The Author(s) 2025.
World J Orthop. Sep 18, 2025; 16(9): 110386
Published online Sep 18, 2025. doi: 10.5312/wjo.v16.i9.110386
Published online Sep 18, 2025. doi: 10.5312/wjo.v16.i9.110386
Table 3 Cumulative percent revision rates for Novation, Alteon, and aggregate antioxidant liner groups
| Novation (n = 461) | Alteon (n = 989) | Aggregate antioxidant (n = 39964) | |
| Years to Revision | Cumulative Percent Revision% [95%CI] (Number at risk) | ||
| 0 | 0.10% [0.00-0.19] (460) | 0.25% [0.12-0.37] (989) | 0.25% [0.20-0.30] (39843) |
| 1 | 0.71% [0.01-1.40] (443) | 1.79% [0.97-2.60] (584) | 1.82% [1.69-1.95] (37561) |
| 2 | 0.83% [0.02-1.64] (394) | 2.09% [1.13-3.03] (162) | 2.12% [1.98-2.27] (35337) |
| 3 | 0.91% [0.02-1.79] (186) | 2.27% [1.23-3.31] (2) | 2.31% [2.16-2.46] (27951) |
- Citation: Jones K, Muehlmann AM, Melvin SM, Oral E, Penrose CT. Short-term survivorship of antioxidant highly cross-linked polyethylene liners in total hip arthroplasty reported in American Joint Replacement Registry. World J Orthop 2025; 16(9): 110386
- URL: https://www.wjgnet.com/2218-5836/full/v16/i9/110386.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i9.110386